An interventional study of KILBON Appliance and CAT appliance in Maxillary Prognathism, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
en-mass retraction by lingual retractor versus clear alighner therapy
Comparative Effectiveness Of Lingual Retractor Versus Clear Aligner Appliances In Adult Patients With Maxillary Dentoalveolar Protrusion Treated By Upper First Premolars Extraction And Enmass Retraction Of Maxillary Anterior Teeth Segment Using Palatal Orthodontic Miniscrews :A Randomized Clinical Trial
11 studies on the registry are indexed under Prognathism; 6 are open to participants now.
Browse Prognathism studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
en-mass retraction by lingual retractor
Device: KILBON Appliance
en-mass retraction by clear aligner
Device: CAT appliance
palatal TAD assissted lingual appliance for en-mass retraction
palatal TAD assissted clear aligner
Patient satisfaction during & after phase I treatment.
questionnaire
Time frame: 6 months
inclination of upper anterior teeth
angle measurement of long axis of maxillary central to maxillary plane in degrees
Time frame: 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Oct 2024; primary completion for Jun 2025, 8 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.